These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 33219462)

  • 1. Inactivated Four-Factor Prothrombin Complex Concentrate Dosing Practices for Reversal of Warfarin-Related Intracranial Hemorrhage.
    Rhoney DH; La M; Merz M; Cook A; Owusu KA; Roels C; Blunck J; Shewmaker J; Sangha KS; Farrokh S; Lewin J; Chester KW; Human T; Bledsoe K; Greene K; Levesque M; Rocker JC; Davis G; Neyens R; Lassiter TF; Adriance SM
    Neurocrit Care; 2021 Aug; 35(1):130-138. PubMed ID: 33219462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of timing and dosing of four-factor prothrombin complex concentrate administration on outcomes in warfarin-associated intracranial hemorrhage.
    Cicci CD; Weiss A; Dang C; Stanton M; Feldman R
    Pharmacotherapy; 2022 May; 42(5):366-374. PubMed ID: 35384000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
    Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
    Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a Pharmacist-Driven Prothrombin Complex Concentrate Protocol on Time to Administration in Patients with Warfarin-associated Intracranial Hemorrhage.
    Corio JL; Sin JH; Hayes BD; Goldstein JN; Fuh L
    West J Emerg Med; 2018 Sep; 19(5):849-854. PubMed ID: 30202498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Warfarin Reversal with 4-Factor Prothrombin Complex Concentrate Compared to 3-Factor Prothrombin Complex Concentrate at a Tertiary Academic Medical Center.
    Al-Majzoub O; Rybak E; Reardon DP; Krause P; Connors JM
    J Emerg Med; 2016 Jan; 50(1):7-13. PubMed ID: 26433428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Hemorrhage with INR Less Than 2.0.
    Zemrak WR; Smith KE; Rolfe SS; May T; Trowbridge RL; Hayes TL; Grindlinger GA; Seder DB
    Neurocrit Care; 2017 Dec; 27(3):334-340. PubMed ID: 28660341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-Factor Versus Four-Factor Prothrombin Complex Concentrate for the Emergent Management of Warfarin-Associated Intracranial Hemorrhage.
    Fischer D; Sorensen J; Fontaine GV
    Neurocrit Care; 2018 Feb; 28(1):43-50. PubMed ID: 28612131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity increases risk of anticoagulation reversal failure with prothrombin complex concentrate in those with intracranial hemorrhage.
    Chu C; Tokumaru S; Izumi K; Nakagawa K
    Int J Neurosci; 2016; 126(1):62-6. PubMed ID: 25430740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of warfarin associated coagulopathy with 4-factor prothrombin complex concentrate in traumatic brain injury and intracranial hemorrhage.
    Yanamadala V; Walcott BP; Fecci PE; Rozman P; Kumar JI; Nahed BV; Swearingen B
    J Clin Neurosci; 2014 Nov; 21(11):1881-4. PubMed ID: 24953825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of four-factor prothrombin complex concentrate fixed, weight-based dosing for reversal of warfarin anticoagulation.
    Endres K; St Bernard R; Chin-Yee I; Hsia C; Lazo-Langner A
    Hematology; 2020 Dec; 25(1):489-493. PubMed ID: 33317427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of coagulopathy using prothrombin complex concentrates is associated with improved outcome compared to fresh frozen plasma in warfarin-associated intracranial hemorrhage.
    Frontera JA; Gordon E; Zach V; Jovine M; Uchino K; Hussain MS; Aledort L
    Neurocrit Care; 2014 Dec; 21(3):397-406. PubMed ID: 24671832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prothrombin complex concentrate accelerates international normalized ratio reversal and diminishes the extension of intracranial hemorrhage in geriatric trauma patients.
    Edavettal M; Rogers A; Rogers F; Horst M; Leng W
    Am Surg; 2014 Apr; 80(4):372-6. PubMed ID: 24887668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid Warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate.
    Woo CH; Patel N; Conell C; Rao VA; Faigeles BS; Patel MC; Pombra J; Akins PT; Axelrod YK; Ge IY; Sheridan WF; Flint AC
    World Neurosurg; 2014 Jan; 81(1):110-5. PubMed ID: 23220122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Warfarin Reversal with Four-Factor Prothrombin Complex Concentrate for Subtherapeutic INR in Intracerebral Hemorrhage.
    Rivosecchi RM; Durkin J; Okonkwo DO; Molyneaux BJ
    Neurocrit Care; 2016 Dec; 25(3):359-364. PubMed ID: 27076286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Effectiveness of Factor VIII Inhibitor Bypassing Activity (FEIBA) and Fresh Frozen Plasma in Oral Anticoagulant-Associated Intracranial Hemorrhage: A Retrospective Analysis.
    Yin EB; Tan B; Nguyen T; Salazar M; Putney K; Gupta P; Suarez JI; Bershad EM
    Neurocrit Care; 2017 Aug; 27(1):51-59. PubMed ID: 28243997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four-factor prothrombin complex concentrate for life-threatening bleeds or emergent surgery: A retrospective evaluation.
    Sin JH; Berger K; Lesch CA
    J Crit Care; 2016 Dec; 36():166-172. PubMed ID: 27546767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propensity score adjusted comparison of three-factor versus four-factor prothrombin complex concentrate for emergent warfarin reversal: a retrospective cohort study.
    Margraf DJ; Seaburg S; Beilman GJ; Wolfson J; Gipson JC; Chapman SA
    BMC Emerg Med; 2020 Nov; 20(1):93. PubMed ID: 33243152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High versus low fixed-dose four factor-prothrombin complex concentrate for warfarin reversal in patients with intracranial hemorrhage.
    Compton F; Hall J; De Simone N; Usmani A; Sarode R; Burner J
    Transfus Apher Sci; 2022 Oct; 61(5):103444. PubMed ID: 35414467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a fixed, weight-based dose of 3-factor prothrombin complex concentrate without adjunctive plasma following warfarin-associated intracranial hemorrhage.
    Mohrien KM; Morgan Jones G; Boucher AB; Elijovich L
    Neurocrit Care; 2014 Aug; 21(1):67-72. PubMed ID: 24781251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 3 Different Prothrombin Complex Concentrate Regimens for Emergent Warfarin Reversal: PCCWaR Study.
    Dietrich SK; Rowe S; Cocchio CA; Harmon AJ; Nerenberg SF; Blankenship PS
    Ann Pharmacother; 2021 Aug; 55(8):980-987. PubMed ID: 33305592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.